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Visceral leishmaniasis (VL) due to Leishmania infantum is a
vector-borne zoonotic disease endemic in Sicily. We report
on a case of VL that occurred in a child with a cardiopathic
condition and Down syndrome.
In January 2005 a 6-month-old child with Down syn-
drome underwent a surgical intervention for congenital
cardiopathy. Two months later the child returned to the
paediatric cardiosurgery department with a 5-day history of
fever. At admission, the patient was febrile, pale, with rare
petechial lesions. A greatly enlarged and hard spleen was
observed. Laboratory examination revealed pancytopenia
and high gammaglobulin value. An immuno-fluorescence
antibody test (IFAT) for Leishmania spp. detected the
presence of anti-Leishmania antibodies. Bone marrow mi-
croscopy and polymerase chain reaction (PCR) revealed
the presence of Leishmania parasites. Treatment with
intravenous liposomal amphotericin B at a dose of 3 mg/kg
per day was administered for 10 consecutive days. Defer-
vescence was obtained after 3 days of treatment.
At the end of therapy splenomegaly and hepatomegaly
were reduced, haematological values were improved and
anti-Leishmania antibodies (by IFAT) were undetectable.
To our knowledge this is the first reported case of VL in
a patient with chromosome 21 trisomy. Down syndrome is
associated with different immune dysfunctions, which have
been correlated to a general predisposition to infection [2,
4, 6]. Moreover, our patient was convalescent from major
surgery, and this might have lead to further immuno-de-
ficiency. In spite of these aggravating factors the patient
showed a typical clinical presentation and recovered in a
way that any child with immuno-competence would nor-
mally recover. Undoubtedly, early diagnosis had an impor-
tant role in the good outcome of the disease in our patient.
The proven efficacy of liposomal amphotericin B in immuno-
deficient subjects [3, 5] and the lack of cardiac side effects,
already reported in a patient with Down syndrome treated
with meglumine antimoniate [1], are the most important
advantages of this therapy, especially in a patient with a
cardiopathic condition. In conclusion, we stress the need for
the paediatrician to consider VL in Down syndrome
children living in endemic areas so as to avoid misdiagnosis
(immunological or neoplastic diseases) and, consequently,
the wrong treatment, such as steroid therapy, which would
make worse the clinical course of leishmanial infection.
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